Virus News and Research

Latest Virus News and Research

New bioengineered lung model could help scientists to advance research in lung conditions

An interdisciplinary team of researchers from McMaster and SickKids are developing a cutting-edge lung model that can better respond to viruses and drug treatments, giving scientists a tool to advance research in lung conditions like COVID-19, cystic fibrosis and allergens for asthma and air pollution.

18 Aug 2021

P681R spike mutation enhances replication efficiency of SARS-CoV-2 delta variant

A team of scientists from the University of Texas, USA, has recently revealed that the P681R spike mutation is responsible for increased infectivity of the delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The P681R spike mutation increases the replication of the delta variant by increasing the dissociation of S1 and S2 subunits at the furin cleavage site. The study is currently available on the bioRxiv* preprint server.

18 Aug 2021

Cote d’Ivoire launches Ebola vaccination of first responders and health workers

Cote d’Ivoire has launched Ebola vaccination of high-risk populations, including health workers and first responders in Abidjan, where an Ebola outbreak was declared on 14 August.

17 Aug 2021

Cote d’Ivoire declares the country’s first case of Ebola since 1994

The Ministry of Health of Cote d’Ivoire today confirmed the country’s first case of Ebola since 1994. This came after the Institut Pasteur in Cote d’Ivoire confirmed the Ebola Virus Disease in samples collected from a patient, who was hospitalized in the commercial capital of Abidjan, after arriving from Guinea.

17 Aug 2021

Researchers receive $26.5 million NIH grant to pursue a new strategy for curing HIV

Over the last 40 years, HIV has shifted from a deadly and mysterious virus to one that can be controlled with daily drugs. But attempts to completely eliminate the virus from the bodies of people living with HIV, curing them for good, have failed.

17 Aug 2021

Delta variant unable to evade antibodies elicited by COVID-19 vaccination, finds study

Despite causing a surge in infections this summer that has resulted in thousands of hospitalizations and deaths, the delta variant of the virus that causes COVID-19 is not particularly good at evading the antibodies generated by vaccination, according to a study by researchers at Washington University School of Medicine in St. Louis.

17 Aug 2021

Study: COVID-19 pandemic resulted in increased rates of intimate partner aggression

Rates of physical and psychological aggression among couples increased significantly after the implementation of shelter-in-place restrictions at the outset of the COVID-19 pandemic, according to a new study led by Georgia State University researchers.

17 Aug 2021

Pregnant and lactating women did not experience increased reactions after COVID-19 vaccination

A survey of more than 17,000 pregnant and lactating individuals who received the COVID-19 vaccine showed that the individuals did not experience symptoms any more severe than their non-pregnant counterparts.

17 Aug 2021

Study investigates airborne and fomite transmission of SARS-CoV-2 in Syrian hamsters

National Institutes of Health scientists studying SARS-CoV-2, the virus that causes COVID-19, have defined in Syrian hamsters how different routes of virus exposure are linked to disease severity.

17 Aug 2021

Weill Cornell Medicine receives $28.5 million Martin Delaney Collaboratory grant to lead HIV cure research

Weill Cornell Medicine has been awarded a five-year, $28.5 million Martin Delaney Collaboratory grant from the National Institutes of Health to lead a multi-institutional effort aimed at finding a cure for HIV.

17 Aug 2021

University of Arkansas receives $6.1 million grant to establish an institute focused on virus research

The National Science Foundation has awarded a $6.1 million grant to the University of Arkansas to establish a research institute focused on virology and virus ecology.

17 Aug 2021

Study explores the role of nasal bacteria and provides clues to developing better flu, COVID-19 vaccines

While gut microbiota play a critical role in the induction of adaptive immune responses to influenza virus infection, the role of nasal bacteria in the induction of virus-specific adaptive immunity is less clear.

17 Aug 2021

UK delivers Oxford-AstraZeneca vaccine doses to Egypt

The package donated by the UK was shipped via COVAX, with the support of UNICEF and WHO, and arrived in Cairo yesterday (16 August).

17 Aug 2021

ERS Genomics and Cellular Engineering Technologies Enter CRISPR/Cas9 License Agreement

ERS Genomics Limited and Cellular Engineering Technologies today announced a non-exclusive license agreement.

17 Aug 2021

‘Tainted’ blood: Covid skeptics request blood transfusions from unvaccinated donors

The nation's roiling tensions over vaccination against covid-19 have spilled into an unexpected arena: lifesaving blood transfusions.

17 Aug 2021

Have vaccines, will travel: On the road with a covid entrepreneur

While many businesses in this southwestern Montana "ghost town" reel in tourists with its mining and Wild West vigilante past, one businessman arrived offering a modern product: covid-19 vaccines.

17 Aug 2021

Researchers confirm the speed, simplicity and accuracy of new COVID-19 testing method

Researchers from the University of Birmingham, U.K., have confirmed the speed, accuracy, and simplicity of a novel, a highly sensitive testing method for COVID-19 that can be deployed at entertainment venues, airport arrival terminals, and in remote settings where clinical testing laboratories are not available.

17 Aug 2021

AIHW report: Modifiable risk factors cause one-third of disease burden

The overall health of Australians continues to improve, however, a new report from the Australian Institute of Health and Welfare for 2018 show that further gains could be achieved by reducing leading risk factors such as tobacco use, overweight, and high blood pressure.

17 Aug 2021

In UK's 1st wave, 10% of COVID infections were acquired in hospitals

Their study published in The Lancet journal involved assessing the magnitude of hospital-acquired COVID-19 in the case of acute and long-term National Health Service (NHS) hospital facilities in the UK during the first wave of the pandemic.

17 Aug 2021

Data reinforces SAB-185’s potential to neutralize SARS-CoV-2 variants

A study, available on the pre-print server bioRxiv*, evaluated the neutralizing capacity of a fully human polyclonal antibody (SAB-185) against the Delta, Kappa, and Lambda variants using a lentiviral-based pseudovirus assay.

17 Aug 2021

Virus News and Research

Latest Virus News and Research

New bioengineered lung model could help scientists to advance research in lung conditions

P681R spike mutation enhances replication efficiency of SARS-CoV-2 delta variant

Cote d’Ivoire launches Ebola vaccination of first responders and health workers

Cote d’Ivoire declares the country’s first case of Ebola since 1994

Researchers receive $26.5 million NIH grant to pursue a new strategy for curing HIV

Delta variant unable to evade antibodies elicited by COVID-19 vaccination, finds study

Study: COVID-19 pandemic resulted in increased rates of intimate partner aggression

Pregnant and lactating women did not experience increased reactions after COVID-19 vaccination

Study investigates airborne and fomite transmission of SARS-CoV-2 in Syrian hamsters

Weill Cornell Medicine receives $28.5 million Martin Delaney Collaboratory grant to lead HIV cure research

University of Arkansas receives $6.1 million grant to establish an institute focused on virus research

Study explores the role of nasal bacteria and provides clues to developing better flu, COVID-19 vaccines

UK delivers Oxford-AstraZeneca vaccine doses to Egypt

ERS Genomics and Cellular Engineering Technologies Enter CRISPR/Cas9 License Agreement

‘Tainted’ blood: Covid skeptics request blood transfusions from unvaccinated donors

Have vaccines, will travel: On the road with a covid entrepreneur

Researchers confirm the speed, simplicity and accuracy of new COVID-19 testing method

AIHW report: Modifiable risk factors cause one-third of disease burden

In UK's 1st wave, 10% of COVID infections were acquired in hospitals

Data reinforces SAB-185’s potential to neutralize SARS-CoV-2 variants

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Virus News and Research

Latest Virus News and Research

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Newsletters you may be interested in